State Pseudoephedrine Proposals Go Above, Beyond Combat Meth Act
This article was originally published in The Tan Sheet
Executive Summary
The National Association of Chain Drug Stores has "concerns" with state bills proposing the establishment of real-time electronic repositories to monitor and limit pseudoephedrine sales, according to the trade group
You may also be interested in...
Pseudoephedrine Tide Turns: Nonprescription Sales Return In Mississippi, Oregon Mulls Change
Mississippi repeals prescription requirement for all pseudoephedrine- and ephedrine-containing drugs while also requiring retailer participation in industry-funded technology for tracking drug sales. Oregon, the only other state with PSE Rx law, is considering repealing it.
Research Refutes Rx-Only Pseudoephedrine Requirements
Research shows Rx requirements “do not effectively reduce methamphetamine’s overall impact on a given state,” CHPA President Scott Melville says. One study found Oregon’s Rx-only law has not dramatically reduced meth lab incidents compared to other states and the second showed the requirement would cost Oklahoma $59 million annually.
Research Refutes Rx-Only Pseudoephedrine Requirements
Research shows Rx requirements “do not effectively reduce methamphetamine’s overall impact on a given state,” CHPA President Scott Melville says. One study found Oregon’s Rx-only law has not dramatically reduced meth lab incidents compared to other states and the second showed the requirement would cost Oklahoma $59 million annually.